相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of fragment-based and computational methods in polypharmacology
Giovanni Bottegoni et al.
DRUG DISCOVERY TODAY (2012)
Tapentadol Extended Release In Adults with Chronic Pain
Sheridan M. Hoy
DRUGS (2012)
Clinical Efficacy and Safety of Tapentadol Immediate Release in the Postoperative Setting
Stephen E. Daniels et al.
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION (2012)
Undesired side effects of tapentadol in comparison to oxycodone
M. Merker et al.
SCHMERZ (2012)
Systematic review of tapentadol in chronic severe pain
Rob Riemsma et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Lessons Learned from Molecular Scaffold Analysis
Ye Hu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia
W. Schroeder et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Treatment of chronic non-cancer pain
Dennis C. Turk et al.
LANCET (2011)
Probing the links between in vitro potency, ADMET and physicochemical parameters
M. Paul Gleeson et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Tramadol increases extracellular levels of serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely-moving rats
P. Bloms-Funke et al.
NEUROSCIENCE LETTERS (2011)
Thermodynamics of Ligand Binding and Efficiency
Charles H. Reynolds et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Antinociceptive and Antihyperalgesic Effects of Tapentadol in Animal Models of Inflammatory Pain
Klaus Schiene et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Efficacy and Safety of Tapentadol Prolonged Release for Chronic Osteoarthritis Pain and Low Back Pain
Bernd Lange et al.
ADVANCES IN THERAPY (2010)
Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study
Marc Afilalo et al.
CLINICAL DRUG INVESTIGATION (2010)
Thermodynamics guided lead discovery and optimization
Gyoergy G. Ferenczy et al.
DRUG DISCOVERY TODAY (2010)
Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally-acting analgesics on the horizon?
Hans G. Kress
EUROPEAN JOURNAL OF PAIN (2010)
Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain
Wolfgang Schroeder et al.
EUROPEAN JOURNAL OF PAIN (2010)
Predicting Polypharmacology by Binding Site Similarity: From Kinases to the Protein Universe
Francesca Milletti et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs
Ye Hu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Molecular Shape and Medicinal Chemistry: A Perspective
Anthony Nicholls et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
IN VITRO AND IN VIVO CHARACTERIZATION OF TAPENTADOL METABOLITES
R. Terlinden et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2010)
Opioid Rotation in the Management of Chronic Pain: Where Is the Evidence?
K. C. P. Vissers et al.
PAIN PRACTICE (2010)
Efficacy and Tolerability of Tapentadol Immediate Release and Oxycodone HCl Immediate Release in Patients Awaiting Primary Joint Replacement Surgery for End-Stage Joint Disease: A 10-Day, Phase III, Randomized, Double-Blind, Active- and Placebo-Controlled Study
Craig Hartrick et al.
CLINICAL THERAPEUTICS (2009)
A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
Stephen E. Daniels et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Role of active metabolites in the use of opioids
Janet K. Coller et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Preclinical and Early Clinical Investigations Related to Monoaminergic Pain Modulation
Kirsty Bannister et al.
NEUROTHERAPEUTICS (2009)
Opioid Metabolism and Effects of Cytochrome P450
Gregory L. Holmquist
PAIN MEDICINE (2009)
Extended-release tramadol (ULTRAM®ER):: A pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain
Robert L. Barkin
AMERICAN JOURNAL OF THERAPEUTICS (2008)
(-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (Tapentadol HCl):: a novel μ-opioid receptor agonist norepinephrine Reuptake inhibitor with broad-spectrum analgesic properties
Thomas M. Tzschentke et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype
Emilio Garcia-Quetglas et al.
PHARMACOLOGICAL RESEARCH (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain
Edgar H. Adams et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
The diversion of Ultram (R), Ultracet (R), and generic tramadol HCl
James A. Inciardi et al.
JOURNAL OF ADDICTIVE DISEASES (2006)
Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products:: results of an abuse monitoring system, 1994-2004
TJ Cicero et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Use of opioids in a Danish population-based cohort of cancer patients
L Jarlbaek et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Facing chirality in the 21st century: Approaching the challenges in the pharmaceutical industry
HJ Federsel
CHIRALITY (2003)
Putting chirality to work: The strategy of chiral switches
I Agranat et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Differential tramadol and O-desmethyl metabolite levels in brain vs. plasma of mice and rats administered tramadol hydrochloride orally
Q Tao et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2002)
Enantiomeric determination of tramadol and its main metabolite O-desmethyltramadol in human plasma by liquid chromatography-tandem mass spectrometry
A Ceccato et al.
JOURNAL OF CHROMATOGRAPHY B (2000)
Affinity, potency and efficacy of tramadol and its metabolites at the cloned human μ-opioid receptor
C Gillen et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
分享论文
